Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the price of this innovative drug and its access have become key issues for patients and healthcare providers. While tirzepatide has been cleared by regulatory agencies, its high-priced nature presents a significant obstacle to many. Ta